His primary areas of study are Cell biology, Internal medicine, Immunology, Stem cell and Mesenchymal stem cell. His Cell biology research incorporates themes from Centrosome, Cell and Cellular differentiation. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Surgery, Oncology and Pathology.
His Immunology research integrates issues from Cancer research, Clinical trial and Transplantation. The Stem cell study combines topics in areas such as Endothelial stem cell and Adult stem cell. His Mesenchymal stem cell study incorporates themes from Molecular biology, Clinical uses of mesenchymal stem cells, Cell culture and Regenerative medicine.
Anthony D. Ho mostly deals with Internal medicine, Immunology, Transplantation, Oncology and Stem cell. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Surgery. His work carried out in the field of Immunology brings together such families of science as Cytotoxic T cell and Cancer research.
His Oncology study combines topics in areas such as Hazard ratio and Lymphoma. His Stem cell study combines topics from a wide range of disciplines, such as Mesenchymal stem cell and Bone marrow. His study in Haematopoiesis is interdisciplinary in nature, drawing from both Progenitor cell and Molecular biology.
Anthony D. Ho focuses on Internal medicine, Oncology, Transplantation, Immunology and Stem cell. Anthony D. Ho combines subjects such as Gastroenterology and Surgery with his study of Internal medicine. The various areas that Anthony D. Ho examines in his Oncology study include Survival rate, Hematology, Retrospective cohort study and Rituximab.
The concepts of his Transplantation study are interwoven with issues in Leukemia, Prospective cohort study and Induction chemotherapy. His research in Stem cell focuses on subjects like Cancer research, which are connected to Mutation. His research in Haematopoiesis intersects with topics in Progenitor cell, Myeloid, Bone marrow and CD34.
His primary scientific interests are in Internal medicine, Immunology, Oncology, Leukemia and Transplantation. His Internal medicine study incorporates themes from Gastroenterology and Surgery. His Immunology research is multidisciplinary, relying on both Clinical research and Haematopoiesis, Stem cell.
Anthony D. Ho has researched Haematopoiesis in several fields, including Myeloid, CD34, Bone marrow and Progenitor cell. His work carried out in the field of Stem cell brings together such families of science as Cancer research and Mesenchymal stem cell. His biological study spans a wide range of topics, including Survival rate, Vorinostat, Soft tissue and Multiple myeloma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood.
Wolfgang Wagner;Frederik Wein;Anja Seckinger;Maria Frankhauser.
Experimental Hematology (2005)
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
Michael Pfreundschuh;Joerg Schubert;Marita Ziepert;Rudolf Schmits.
Lancet Oncology (2008)
Replicative senescence of mesenchymal stem cells: a continuous and organized process.
Wolfgang Wagner;Patrick Horn;Mirco Castoldi;Anke Diehlmann.
PLOS ONE (2008)
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Norbert Schmitz;Lorenz Trümper;Marita Ziepert;Maike Nickelsen.
Blood (2010)
Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma.
Martin Körbling;Bernd Dorken;Bernd Dorken;Anthony D. Ho;Anthony D. Ho;Antonio Pezzutto;Antonio Pezzutto.
Blood (1986)
Human haematopoietic stem cell lineage commitment is a continuous process
Lars Velten;Simon F. Haas;Simon Raffel;Simon Raffel;Sandra Blaszkiewicz.
Nature Cell Biology (2017)
Aging and replicative senescence have related effects on human stem and progenitor cells.
Wolfgang Wagner;Wolfgang Wagner;Simone Bork;Patrick Horn;Damir Krunic.
PLOS ONE (2009)
Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial
Hans Theodor Eich;Volker Diehl;Helen Görgen;Thomas Pabst.
Journal of Clinical Oncology (2010)
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
B. M. Beckermann;Georgios Kallifatidis;Georgios Kallifatidis;A. Groth;A. Groth;D. Frommhold.
British Journal of Cancer (2008)
Rituximab therapy of patients with B-cell chronic lymphocytic leukemia.
Dieter Huhn;Christoph von Schilling;Martin Wilhelm;Anthony D. Ho.
Blood (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University Hospital Heidelberg
German Cancer Research Center
Heidelberg University
TU Dresden
TU Dresden
Saarland University
University Hospital Heidelberg
Friedrich Schiller University Jena
TU Dresden
University of Würzburg
The Ohio State University
Microsoft (United States)
Iowa State University
Tianjin University
Tokyo Institute of Technology
University of North Carolina Wilmington
University of Maine
Aberystwyth University
University of California, San Francisco
University of Zurich
King Abdullah University of Science and Technology
Instituto Português do Mar e da Atmosfera
Washington University in St. Louis
University of British Columbia
City University of New York
University of Oxford